National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

STATUTORY RULES.

1964. No. 135.

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1964.*

I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1964.

Dated this twenty-ninth

day of October, 1964.

DE L’ISLE

Governor-General.

By His Excellency’s Command,

(SGD.) H. W. WADE

Minister of State for Health.

Amendments of the National Health (Pharmaceutical Benefits) Regulations. 

Commencement.

1. These Regulations shall come into operation on the first day of November, 1964.

Standards of composition and purity of pharmaceutical benefits and additives.

2. Regulation 35 of the National Health (Pharmaceutical Benefits) Regulations is amended—

(a) by omitting from sub-regulation (2.) the words “Where the letters” and inserting in their stead the words “Subject to the next succeeding sub-regulation, where the letters”; and

(b)by inserting after sub-regulation (2.) the following sub-regulation:—

“(2a.) Where the letters ‘A.P.F. 1955’ appear after the name of the pharmaceutical benefit or the additive, the standards of composition and purity are those constituted by the description of that pharmaceutical benefit and its ingredients, or of that additive, as the case may be, in the edition of the book called the Australian Pharmaceutical Formulary published by the Pharmaceutical Association of Australia in the year 1955 as subsequently amended.”.

* Notified in the Commonwealth Gazette on 30th October, 1964.

  Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137; 1962, Nos. 34, 101 and 114; 1963, Nos. 34, 69 and 107; and 1964, Nos. 12 and 57.

12767/64.—Price 2s. 6d. 10/13.10.1964.

First, Second, Third, Fourth and Fifth Schedules.

3. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—

FIRST SCHEDULE.

Regulation 10.

Drugs and Medicinal Preparations in the British Pharmacopoeia that are not to be supplied as, or except as specially provided used in, pharmaceutical Benefits.

Acetomenaphthone.	Cresol and Soap Solution.
Acetomenaphthone Tablets.	Cresol.
Acetrizoic Acid.	Crotamiton.
Alcohol (95%).	Cyanocobalamin.
Dilute Alcohols.	Cyclizine Tablets.
Dehydrated Alcohol.	Cyclobarbitone Calcium.
Almond Oil.	Cyclomethycaine Sulphate.
Amethocaine Hydrochloride.	Cyclopropane.
Amodiaquine Hydrochloride.	Dapsone.
Amphetamine Sulphate.	Deoxycortone Trimethylacetate.
Amylobarbitone Sodium Tablets.	Dequalinium Acetate.
Antazoline Hydrochloride.	Dequalinium Chloride.
Antimony Potassium Tartrate.	Dexamethasone.
Antimony Potassium Tartrate Injection.	Dexamethasone Acetate.
Antimony Sodium Tartrate.	Dexamphetamine Sulphate.
Antimony Sodium Tartrate Injection.	Dextromethorphan Hydrobromide.
Apomorphine Hydrochloride.	Dextromethorphan Tablets.
Apomorphine Injection.	Diamorphine Hydrochloride.
Bacillus Calmette-Guérin Vaccine.	Diamorphine Injection.
Bacitracin.	Dibromopropamidine Isethionate.
Bemegride.	Dichlorphenamide.
Benzhexol Hydrochloride.	Diethazine Hydrochloride.
Benztropine Methanesulphonate.	Diethylcarbamazine Citrate.
Botulinum Antitoxin.	Digitoxin.
Busulphan.	Diloxanide Furoate.
Butobarbitone.	Dimenhydrinate.
Calciferol.	Dimenhydrinate Injection.
Caramiphen Hydrochloride.	Dimenhydrinate Tablets.
Caraway.	Dimercaprol.
Carbachol.	Dimethisterone.
Carbimazole.	Dimethisterone Tablets.
Carbon Dioxide.	Diodone Injection.
Carbromal Tablets.	Diphtheria and Pertussis Vaccine.
Cardamom Fruit.	Dipipanone Hydrochloride.
Cascara.	Dipipanone Injection.
Catgut, Sterilised Surgical.	Domiphen Bromide.
Cellulose, Oxidised.	Edrophonium Chloride.
Cetylpyridinium Chloride.	Emetine and Bismuth Iodide.
Chlorambucil.	Emetine Hydrochloride.
Chlorcyclizine Hydrochloride.	Erythromycin.
Chloroquine Phosphate.	Ethinyloestradiol.
Chloroquine Sulphate.	Ethisterone.
Chlorothiazide.	Ethopropazine Hydrochloride.
Chlorphenesin.	Ethotoin.
Chlorpropamide.	Ethyl Chloride.
Chorionic Gonadotrophin.	Ethyl Oleate.
Chorionic Gonadotrophin Injection.	Ethylenediamine Hydrate.
Cinchocaine Hydrochloride.	Eugenol.
Cinnamon.	Fludrocortisone Acetate.
Citric Acid, Anhydrous.	Fluoxymesterone.
Cochineal.	Gallamine Triethiodide.
Colchicine.	Gallamine Injection.
Colchicum Conn.	Gelatin Sponge, Absorbable.
Colchicum Liquid Extract.	Gentian.
Coriander.	Ginger.
Corticotrophin.	Glutethimide.

First Schedule—continued.

Griseofulvin.	Methandienone.
Guanethidine Sulphate.	Methoin.
Halothane.	Methyl Hydroxybenzoate.
Helium.	Methylamphetamine Hydrochloride.
Heparin.	Methylthiouracil.
Hexamethonium Tartrate.	Methylthiouracil Tablets.
Hexamethonium Tartrate Injection.	Methyprylone.
Hexylresorcinol.	Methyprylone Tablets.
Histamine Acid Phosphate.	Mustine Hydrochloride.
Human Blood, Whole.	Nalorphine Hydrobromide.
Human Red Blood Corpuscles, Concentrated.	Nandrolone Phenylpropionate.
Human Fibrin Foam.	Naphazoline Hydrochloride.
Human Fibrinogen.	Neostigmine Bromide.
Human Gamma Globulin.	Nicotinic Acid.
Human Gamma Globulin Injection.	Nikethamide.
Human Plasma, Dried.	Nikethamide Injection.
Human Serum, Dried.	Nitrous Oxide.
Human Thrombin.	Norethisterone.
Hydrallazine Hydrochloride.	Norethisterone Tablets.
Hydrallazine Tablets.	Noscapine.
Hydrochlorothiazide.	Nux Vomica.
Hydrocortisone Ointment.	Oestradiol Benzoate.
Hydrocortisone Acetate Ointment.	Opium.
Hydrocortisone Hydrogen Succinate.	Opium, Powdered.
Hydroflumethiazide.	Orange Peel, Dried Bitter.
Hydrogen Peroxide Solution, Strong.	Orange Peel, Fresh Bitter.
Hydroxocobalamin.	Oxygen.
Hydroxychloroquine Sulphate.	Oxytetracycline Dihydrate.
Hyoscyamus.	Paramethadione.
Imipramine Hydrochloride.	Pempidine Tartrate.
Imipramine Tablets.	Pentamidine Isethionate.
Indigo Carmine.	Pentamidine Injection.
Influenza Vaccine.	Perphenazine.
Iodipamide Methylglucamine Injection.	Perphenazine Tablets.
Iodised Oil Fluid Injection.	Pethidine Tablets.
Iodised Oil Viscous Injection.	Phanquone.
Iopanoic Acid.	Phanquone Tablets.
Iopanoic Acid Tablets.	Phenelzine Sulphate.
Iophendylate Injection.	Phenelzine Tablets.
Ipecacuanha, Prepared.	Phenindamine Tartrate.
Ipecacuanha and Opium Tablets.	Phenindione.
Isoniazid.	Phenolphthalein Tablets.
Isopropyl Alcohol.	Phenolsulphonphthalein.
Lead Acetate.	Phenoxybenzamine Hydrochloride.
Lead Monoxide.	Phenoxymethylpenicillin.
Lemon Peel, Dried.	Phentolamine Hydrochloride.
Lignocaine Hydrochloride.	Phentolamine Tablets.
Lignocaine and Adrenaline Injection.	Phentolamine Methanesulphonate.
Lignocaine Hydrochloride Injection.	Phentolamine Injection.
Liothyronine Sodium.	Phenylbutazone.
Lucanthone Hydrochloride.	Phytomenadione.
Lucanthone Tablets.	Phytomenadione Capsules.
Magnesium Stearate.	Phytomenadione Tablets.
Male Fern.	Picrotoxin.
Maleic Acid.	Piperazine Phosphate.
Mannitol.	Piperocaine Hydrochloride.
Mecamylamine Hydrochloride.	Poliomyelitis Vaccine (Inactivated).
Melarsoprol.	Poliomyelitis Vaccine (Oral).
Menaphthone Sodium Bisulphite.	Potassium Chloride Injection.
Mepacrine Hydrochloride.	Potassium Perchlorate.
Mephentermine Sulphate.	Prednisone Acetate.
Meprobamate.	Primaquine Phosphate.
Meprobamate Tablets.	Primidone.
Mercaptopurine.	Probenecid.
Mersalyl Acid.	Procaine and Adrenaline Injection.
Methadone Hydrochloride.	Prochlorperazine Maleate.

First Schedule—continued.

Prochlorperazine Tablets.

Stibophen Injection.

Procyclidine Hydrochloride.

Stramonium.

Proguanil Hydrochloride.

Sulphadimidine Sodium.

Promazine Hydrochloride.

Sulphamethizole.

Promazine Injection.

Sulphamethoxypyridazine.

Promazine Tablets.

Sulphasomidine.

Promethazine Theoclate.

Sulphasomidine Tablets.

Promethazine Theoclate Tablets.

Sulphobromophthalein Sodium.

Propyl Gallate.

Suramin.

Propyl Hydroxybenzoate.

Suramin Injection.

Propyliodone.

Suxamethonium Bromide.

Propyliodone Injection.

Suxamethonium Chloride.

Propyliodone Oily Injection.

Testosterone.

Propylthiouracil.

Testosterone Phenylpropionate.

Pyridostigmine Bromide.

Testosterone Phenylpropionate Injection.

Pyrimethamine.

Tetrachloroethylene.

Quillaia.

Tetrachloroethylene Capsules.

Rabies Antiserum.

Thiambutosine.

Rabies Vaccine.

Thiomersal.

Schick Control.

Thiopentone Sodium.

Senna Leaf.

Thiopentone Injection.

Sesame Oil.

Thioridazine Hydrochloride.

Soda Lime.

Thyroid.

Sodium Acetrizoate Injection.

Thyroxine Sodium.

Sodium Anoxynaphthonate.

Tolazoline Hydrochloride.

Sodium Antimonylgluconate.

Tolbutamide.

Sodium Antimonylgluconate Injection.

Trichloroethylene.

Sodium Aurothiomalate.

Trifluoperazine Hydrochloride.

Sodium Bicarbonate Injection.

Tripelennamine Hydrochloride.

Sodium Calciumedetate.

Tryparsamide.

Sodium Chromate (51 Cr) Injection.

Tryparsamide Injection.

Sodium Diatrizoate.

Tuberculin, Old.

Sodium Diatrizoate Injection.

Tuberculin Purified Protein Derivative.

Sodium Fluoride.

Tubocurarine Chloride.

Sodium Iodide (131 I) Injection.

Tubocurarine Injection.

Sodium Iodide (131 I) Solution.

Typhoid-Paratyphoid A and B and

Cholera Vaccine.

Sodium Lauryl Sulphate.

Sodium Phosphate (32 P) Injection.

Typhoid-Paratyphoid A and B and

Tetanus Vaccine.

Sodium Stibogluconate.

Sodium Stibogluconate Injection.

Typhoid-Paratyphoid A, B, and C

Vaccine.

Solapsone.

Solapsone Tablets.

Vinyl Ether.

Staphylococcus Antitoxin.

Vitamin A Ester Concentrate.

Stibophen.

Yellow Fever Vaccine.

SECOND SCHEDULE.

Regulation 10 (3).

Allowable Compounds (if any) of Certain Drugs or Medicinal Preparations.

Pharmaceutical Benefits.	Allowable Compounds (if any).
Acrylic Resin .......................................	—
Adrenaline Acid Tartrate, B.P. ..............	—
Aluminium Powder, B.P.C. ...................	Aluminium Powder B.P.C. with Liquid Paraffin B.P. and Zinc Oxide Ointment B.P.

Second Schedule—continued.

Pharmaceutical Benefits.	Allowable Compounds (if any).
Aluminium Hydroxide Gel Dried, B.P.	Aluminium Hydroxide Gel Dried B.P. with Magnesium Hydroxide B.P.C.
Aluminium Hydroxide Gel Dried B.P. with Magnesium Trisilicate B.P.
Aluminium Hydroxide Gel Dried B.P. with Magnesium Carbonate B.P.
Aluminium Hydroxide Gel Dried B.P. with Magnesium Trisilicate B.P. and Magnesium Hydroxide B.P.C.
Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Aluminium Hydroxide Gel Dried B.P.
Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel B.P.
Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel B.P.
Amphotericin B. .......................................	Tetracycline with a buffering agent and Amphotericin B.
Aneurine Hydrochloride, B.P.....................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Antazoline Sulphate .................................	Antazoline Sulphate with Naphazoline Nitrate B.P.
Ascorbic Acid, B.P. ..................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Attapulgite ...............................................	Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Hydrated Alumina Powder B.P.
Bacitracin Eye Drops ................................	—
Benzol (Commercial) ...............................	—
Betamethasone Disodium Phosphate..........	—
Betamethasone Phosphate .........................	—
Calciferol Solution, B.P. ...........................	—
Calcium Lactobionate ...............................	Thenalidine with Calcium Lactobionate
Carbinoxamine Maleate ............................	—
Carbromal, B.P. .......................................	Carbromal B.P., with Pentobarbitone Sodium B.P.
Chloramine, B.P.C. ..................................
Chloramphenicol, B.P. ..............................	Chloramphenicol B.P. with Polymyxin B. Sulphate B.P.
Chlorhexidine Gluconate ..........................	—
Chlorpheniramine Maleate, B.P.................	—
Chlorpromazine Hydrochloride, B.P...........	—
Chlortetracycline Hydrochloride, B.P.........	—
Clemizole Tannate ...................................	—
Cortisone Acetate, B.P..............................	—
Cymogran ................................................	—
Cyproheptadine Hydrochloride .................	—
Cyclizine Hydrochloride, B.P. ...................	Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride B.P.
Demecarium Bromide ..............................	—
Demethylchlortetracycline Hydrochloride, B.P.	—
Dexchlorpheniramine Maleate ..................	—
Dextran ...................................................	Dextran with Dextrose B.P.
Dextran in Normal Saline
Dicyclomine Hydrochloride, B.P.C.	—
Dienoestrol, B.P........................................	—
Digoxin, B.P.............................................	—

Second Schedule—continued.

Pharmaceutical Benefits.	Allowable Compounds (if any).
Dihydrostreptomycin Sulphate, B.P. 1958	Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Hydrated Alumina Powder B.P.
Dihydrostreptomycin Sulphate B.P. 1958 with Kaolin, Pectin and Aluminium Hydroxide Gel
Dihydrotachysterol ...................................	—
Dimethicone ............................................	—
Diphenhydramine Hydrochloride, B.P.	Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. 1959 and Diphenhydramine Hydrochloride B.P.
Diphenylpyraline Hydrochloride ...............	—
Diphtheria Vaccine, B.P............................	Diphtheria and Tetanus Vaccine B.P.
Diphtheria, Tetanus and Pertussis Vaccine B.P.
Dyflos, B.P.C. ..........................................	—
Ecothiopate Iodide ...................................	—
Entsufon ..................................................	Hexachlorophane B.P. with Entsufon
Ergometrine Maleate ................................	Oxytocin with Ergometrine Maleate
Ergotamine Tartrate, B.P. .........................	Ergotamine Tartrate B.P. with Caffeine B.P.
Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride B.P.
Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. 1959 and Diphenhydramine Hydrochloride B.P.
Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P.
Erythromycin Oral Suspensions ................	—
Ethosuximide ...........................................	—
Ferric Hydroxide ......................................	—
Ferrous Aminoacetosulphate .....................	—
Ferrous Gluconate, B.P..............................	—
Ferrous Succinate .....................................	—
Framycetin Sulphate .................................	—
Galactomin ..............................................	—
Glucose Indicator .....................................	—
Gramicidin ..............................................	Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin
Hamamelis Dry Extract, B.P.C. .................	Hamamelis Dry Extract B.P.C. with Zinc Oxide, B.P.
Hexachlorophane, B.P. .............................	Hexachlorophane B.P. with Entsufon
Hexachlorophane B.P. with Lissapol
Hexachlorophane B.P. in Soap Solution
Hydrocortisone, B.P..................................	—
Hydrocortisone Acetate, B.P......................	Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P.
Ipecacuanha, B.P......................................	Phenolphthalein B.P. with Aloin B.P.C., Dry Extract of Belladonna B.P., Strychnine B.P.C. 1959 and Ipecacuanha B.P.
Isoprenaline Hydrochloride .......................	—
Kanamycin Sulphate, B.P.C. .....................	—
Levallorphan Tartrate, B.P. .......................	Levallorphan Tartrate B.P. with Pethidine Hydrochloride B.P.
Lissapol ...................................................	Lissapol with Spearmint Oil B.P.C. and Cetrimide B.P.
Hexachlorophane B.P. with Lissapol
Lofenalac ................................................	—
Magnesium Bicarbonate Solution, B.P. 1948	—
Magnesium Chloride ................................	Ammonium Chloride B.P. with Sodium Chloride B.P., Potassium Chloride B.P. and Magnesium Chloride
Sodium Lactate with Potassium Chloride B.P., Magnesium Chloride and Sodium Chloride B.P.
Mebhydrolin Napadisylate, B.P.C.	—
Meclozine Hydrochloride, B.P. .................	Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P.
Mepyramine Maleate, B.P. .......................	—
Methdilazine Hydrochloride .....................	—

Second Schedule—continued.

Pharmaceutical Benefits.	Allowable Compounds (if any).
Methyl Glucamine ....................................	Theophylline B.P. with Methyl Glucamine
Minafen ...................................................	—
Naphazoline Nitrate, B.P. .........................	Naphazoline Nitrate B.P. with Antazoline Sulphate
Neomycin Sulphate, B.P. ..........................	Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P.
Polymyxin B. Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P.
Neomycin Sulphate B.P. with Kaolin B.P.
Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin
Neostigmine Methylsulphate B.P. .............	—
Nicotinamide, B.P. ...................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Nitrofurantoin, B.P. ..................................	—
Nystatin, B.P. ...........................................	Tetracycline with a buffering agent and Nystatin B.P.
Oxytetracycline Hydrochloride, B.P.	Oxytetracycline Hydrochloride B.P. with Polymyxin B. Sulphate B.P.
Oxytocin .................................................	Oxytocin with Ergometrine Maleate
Pancreatin Enzyme U.S.N.F. XI ................	—
Papaveretum, B.P.C..................................	Papaveretum B.P.C. with Hyoscine Hydrobromide B.P.
Paracetamol, B.P.......................................	—
Penicillin, Benethamine, B.P.C. ................	Penicillin, Benethamine B.P.C. with Procaine Penicillin B.P. and Sodium Penicillin B.P.
Penicillin, Benzathine, B.P. .......................	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
Penicillin, Benzyl, B.P. .............................	Penicillin, Benzyl B.P. with Streptomycin Sulphate B.P.
Fortified Procaine Penicillin Injection B.P.
Penicillin, Benzyl B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
Penicillin, Phenoxymethyl (Benzathine, Calcium, Hydrabamine or Potassium Salt or Free Acid)	-
Penicillin, Potassium, B.P. ........................	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
Penicillin, Procaine, B.P. ..........................	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
Fortified Procaine Penicillin Injection B.P.
Penicillin, Benethamine B.P.C. with Procaine Penicillin B.P. and Sodium Penicillin B.P.
Penicillin, Benzyl B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
Penicillin, Sodium, B.P. ............................	Penicillin, Benethamine B.P. with Procaine Penicillin and Sodium Penicillin B.P.
Pentolinium Tartrate, B.P. .........................	Pentolinium Tartrate B.P. with Ephedrine Hydrochloride B.P.
Pertussis Vaccine, B.P. .............................	Diphtheria, Tetanus and Pertussis Vaccine B.P.
Pethidine Hydrochloride, B.P. ...................	Pethidine Hydrochloride B.P. with Levallorphan Tartrate B.P.
Pethidine Hydrochloride B.P. with Scopolamine Hydrobromide B.P.
Phenethicillin Potassium ...........................	—
Pheniramine Maleate, B.P. ........................	—
Phenytoin ................................................	—
Pipenzolate Methobromide .......................	—
Piperazine Citrate, B.P. .............................	—
Pituitary (Posterior Lobe), Powdered, B.P.C.	—

Second Schedule—continued.

Pharmaceutical Benefits.	Allowable Compounds (if any).
Polymyxin B. Sulphate, B.P. .....................	Chloramphenicol B.P. with Polymyxin B. Sulphate B.P.

Oxytetracycline Hydrochloride B.P. with Polymyxin B. Sulphate B.P.
Polymyxin B. Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P.
Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin
Polymyxin B. Sulphate with Propylene Glycol and Acetic Acid
Prednisolone, B.P. ....................................	Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel B.P.
Methylprednisolone, B.P. .........................	—
Prednisolone Sodium Hemisulphate	—
Prednisolone Sodium Phosphate, B.P.C.	—
Prednisolone Trimethylacetate, B.P.	—
Prednisone, B.P. .......................................	Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel P.P.
Promethazine Hydrochloride, B.P.	—
Riboflavine, B.P.......................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Senna Fruit, B.P........................................	—
Silver Nitrate, Toughened, B.P. .................	—
Sobee ......................................................	—
Sodium Lactate ........................................	Sodium Lactate with Potassium Chloride B.P. and Sodium Chloride B.P.
Sodium Lactate with Potassium Chloride B.P., Magnesium Chloride and Sodium Chloride B.P.
Sodium Lactate with Sodium Chloride B.P. and Dextrose B.P.
Sodium Lactate with Sodium Chloride B.P.
Sodium Lactate with Potassium Chloride B.P. and Dextrose B.P.
Sodium Potassium Tartrate B.P.C.	Compound Effervescent Powder, B.P.C.
Sodium Tauroglycocholate B.P.C. 1954	Sodium Tauroglycocholate B.P.C. 1954 with Cascara Dry Extract B.P.
Spearmint Oil, B.P.C. ...............................	Lissapol with Spearmint Oil B.P.C. and Cetrimide B.P.
Sulphacetamide, B.P.C. ............................	Sulphacetamide B.P.C. with Sulphamerazine B.P. 1958 and Sulphadiazine B.P.
Sulphadimethoxine, B.P.C. .......................	—
Sulphafurazole, B.P. .................................	—
Sulphamerazine, B.P. 1958 .......................	Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphathiazole B.P.C:
Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphacetamide B.P.C.
Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphadimidine B.P.
Sulphamethoxydiazine ..............................	—
Sulphamethoxypyridazine N-Acetyl	—
Sulphaphenazole, B.P.C. ...........................	—
Sulphathiazole, B.P.C. ..............................	Sulphathiazole B.P.C. with Sulphamerazine B.P. 1958 and Sulphadiazine B.P.
Surgical Cement .......................................	—
Tacrine ....................................................	Morphine Sulphate B.P. with Tacrine
Tetanus Vaccine, B.P. ..............................	Diphtheria and Tetanus Vaccine B.P.
Diphtheria, Tetanus and Pertussis Vaccine B.P.
Tetracycline Hydrochloride, B.P. ..............	Tetracycline Hydrochloride B.P. with a buffering agent
Tetracycline .............................................	Tetracycline with a buffering agent and Amphotericin B.
Tetracycline with a buffering agent and Nystatin B.P.

Second Schedule—continued.

Pharmaceutical Benefits.	Allowable Compounds (if any).
Thenalidine ............................................	Thenalidine with Calcium Lactobionate
Thenalidine Tartrate ...............................	Thenalidine Tartrate with Calcium Lactate B.P. and Calcium Gluconate B.P.
Theobromine, B.P.C. ..............................	Theobromine B.P.C. with Phenobarbitone B.P.
Thioridazine ...........................................	—
Tragacanth (Gum Karaya) .......................	—
Trimeprazine Tartrate, B.P.C. ..................	—
Triprolidine Hydrochloride, B.P.C.	—
Vasopressin ...........................................	—
Velactin .................................................	—
Viomycin Pantothenate ...........................	Viomycin Sulphate B.P. with Viomycin Pantothenate
Viomycin Sulphate, B.P. .........................	Viomycin Sulphate B.P. with Viomycin Pantothenate
Viprynium Embonate ..............................	—
Vitamin A ..............................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Vitamin D ..............................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D

THIRD SCHEDULE.

Regulation 11.

Drugs and Medicinal Preparations Additional to the Drugs and Medicinal Preparations in the British Pharmacopoeia.

Acetarsol Diethylamine.	Bacitracin Eye Drops.
Acetazolamide Sodium.	Beeswax, Yellow, B.P.C.
Acetohexamide.	Belladonna Suppository, B.P. 1948.
Acidified Golden Syrup, A.P.F. 1955.	Benedict’s Solution, A.P.F.
Acriflavine, B.P.C.	Benzalkonium Chloride.
Acrylic Resin.	Benzoinated Lard, B.P.C. 1954.
Adrenaline Hydrochloride.	Benzoin Compound Tincture, B.P.C.
Adrenaline Mucate.	Benzoin Tincture, B.P.C.
Agar B.P.C. 1954.	Benzol (Commercial).
Alkavervir.	Benzylpenicillin in Oil.
Aloin B.P.C.	Bephenium Hydroxynaphthoate, B.P.C.
Almond Oil Volatile Bitter, B.P.C. 1959.	Betamethasone.
Aloxidone.	Betamethasone Disodium Phosphate.
Aluminium Acetate Solution, B.P.C.	Betamethasone Phosphate.
Aluminium Hydroxide Mixture, A.P.F.	Bethanidine Sulphate.
Aluminium Hydroxide Mixture, A.P.F. 1955.	Bismuth Glycollylarsanilate, B.P.C.
	Bismuth Subgallate, B.P.C.
Aluminium Sodium Polyhydroxy Monocarbonate Hexitol Complex.	Bretylium Tosylate.
	Brown Snake Antivenene.
Aluminium Powder, B.P.C.	Buchu Concentrated Infusion, B.P.C. 1954.
Amaranth Solution, A.P.F.
Amaranth Solution, B.P.C.	Butabarbital Sodium.
Amidopyrine, B.P.C. 1954.	Butyl Aminobenzoate, B.P. 1953.
Ammonia Aromatic Spirit, B.P.C.	Cade Oil, B.P.C.
Ammonia Solution Strong, B.P.C.	Caffeine and Sodium Benzoate, B.P.C. 1954.
Ammonium Bicarbonate, B.P.C.
Ammonium Bromide, B.P.C.	Caffeine Citrate, B.P.C. 1959.
Amphotericin B.	Cajuput Spirit, B.P. 1948.
Ampicillin.	Calamine Cream, A.P.F. 1955
Antazoline Methanesulphonate, B.P.C.	Calcium Aurothiomalate.
Antazoline Sulphate.	Calcium Di-Oxytetracycline.
Attapulgite.	Calcium Gluconogalactogluconate.
Aurothioglucose.	Calcium Lactobionate.

Third Schedule—continued.

Calcium Phosphate, B.P.C.

Calumba, Concentrated Infusion, B.P. 1948.

Calumba Tincture, B.P. 1948.

Capsicum Ointment, B.P.C.

Capsicum Tincture, B.P.C.

Carbamazepine.

Carbarsone, B.P.C.

Carbinoxamine Maleate.

Cardamom Aromatic Tincture, B.P.C.

Catechu Tincture, B.P.C.

Cetyl Alcohol Compound.

Chloramine, B.P.C.

Chloramphenicol Palmitate, B.P.C.

Chloramphenicol Stearate.

Chloramphenicol Succinate.

Chlorazanil Hydrochloride.

Chlorhexidine Diacetate.

Chlorhexidine Gluconate.

Chlorobenzol Disulphonamide.

Chlorotrianisene, B.P.C.

Chlorthalidone, B.P.C.

Choline Theophyllinate, B.P.C.

Cinnamon Spirit, B.P.C. 1949.

Cinnamon Water, Concentrated, B.P.C.

Clemizole Hydrochloride.

Clemizole Tannate.

Clopamide.

Clove, Concentrated Infusion, B.P.C. 1954.

Cloxacillin Sodium.

Coal Tar, B.P.C.

Cochineal Tincture, B.P. 1948.

Coconut Oil, B.P.C. 1949.

Codeine, B.P.C. 1954.

Colistin.

Copper Sulphate, B.P.C.

Creosote, B.P.C. 1959.

Cudbear Tincture, A.P.F. 1947.

Curd Soap, B.P.C.

Cyclopenthiazide.

Cyclophosphamide.

Cyclothiazide.

Cycrimine Hydrochloride.

Cymogran.

Cyproheptadine Hydrochloride.

Death Adder Antivenene.

Demecarium Bromide.

Deoxycortone Glucoside.

Desferrioxamine.

Deslanoside.

Dexamethasone Sodium Phosphate.

Dexchlorpheniramine Maleate.

Dextran.

Dextran Iron.

Dextriferron.

Dicyclomine Hydrochloride B.P.C.

Digitalis Tincture, B.P.C. 1959.

Dihydroergotamine Methanesulphonate.

Dihydromorphinone Hydrochloride, B.P.C. 1949.

Dihydrostreptomycin Sulphate, B.P. 1958.

Dihydrotachysterol.

Dimethicone, B.P.C.

Diphenylpyraline Hydrochloride.

Dipyridamole.

Disodium Stilboestrol Diphosphate.

Dithiazanine Iodide.

Dyflos, B.P.C.

Ecothiopate iodide.

Entsufon.

Ephedrine, B.P.C.

Ergot, Liquid Extract, B.P. 1914.

Erythromycin Ethyl Succinate.

Erythromycin Glucoheptonate.

Erythromycin Lactobionate.

Erythromycin Stearate.

Ethanolamine, B.P.C.

Ethanolamine Oleate.

Ether Nitrous Spirit, B.P.C. 1959.

Ethionamide.

Ethosuximide.

Ethoxzolamide.

Ethyl Biscoumacetate, B.P.C.

Ethylidene Dicoumarin.

Ethylnoradrenaline Hydrochloride.

Ethyloestrenol.

Eucalyptol, B.P.C.

Extract of Ox Bile, B.P. 1948.

Ferric Hydroxide.

Ferrous Aminoacetosulphate.

Ferrous Carbonate Saccharated, B.P.C. 1959.

Ferrous Phosphate Compound Syrup, B.P.C.

Ferrous Phosphate with Quinine and Strychnine Syrup, B.P.C.

Ferrous Succinate.

Folinic Acid.

Framycetin Sulphate.

Fursemide.

Fusidic Acid, Diethanolamine Salt.

Fusidic Acid, Sodium Salt.

Galactomin.

Gall and Opium Ointment, B.P.C.

Gelsemium Tincture, B.P.C.

Glucagon Hydrochloride.

Glucose Indicator.

Glycerophosphate Compound Syrup, A.P.F. 1955.

Gramicidin.

Haemophilus Influenza Bacterial Serum.

Hamamelis Dry Extract, B.P.C.

Hamamelis Liquid Extract, B.P.C.

Heparin Retard.

Hexocyclium Methylsulphate.

Honey, Purified, B.P.C.

Hydrargaphen.

Hydrocyanic Acid, Dilute, B.P.C. 1954.

Hydroxyprogesterone Caproate.

Hyoscine Methobromide.

Hypophosphorous Acid, Dilute, B.P.C.

Insulin Injection, specially purified.

Insulin Isophane Injection, specially purified.

Insulin Injection, Special P (Pig).

Iodochlorhydroxyquinoline.

Iodoform, B.P.C. 1954.

Iron Aminoates.

Iron Oxide Saccharated.

Iron Sorbitol Complex.

Third Schedule—continued.

Isoprenaline Hydrochloride.

Isopropamide Iodide.

Isothipendyl Hydrochloride, B.P.C.

Kanamycin Sulphate, B.P.C.

Lanatoside-C.

Lavender Spike Oil, B.P.C.

Lemon Tincture, B.P. 1958.

Lissapol.

Lobelia Ethereal Tincture, B.P.C.

Lofenalac.

Magenta, B.P.C.

Magnesium Bicarbonate Solution, B.P. 1948.

Magnesium Chloride.

Magnesium Hydroxide, B.P.C.

Mebhydrolin Napadisylate, B.P.C.

Medroxyprogesterone Acetate.

Mercaptomerin Sodium.

Mercuric Chloride, B.P.C.

Mercurous Chloride Ointment, B.P. 1948.

Mercury Compound Ointment, B.P.C. 1959.

Mestanolone.

Metaraminol Bitartrate.

Metformin Hydrochloride.

Methacycline.

Methandriol.

Methazolamide.

Methdilazine Hydrochloride.

Methenamine Mandelate.

Methenolone Acetate.

Methenolone Oenanthate.

Methotrexate.

Methoxamine Hydrochloride, B.P.C.

Methsuximide.

Methyclothiazide.

Methyldopa.

Methyl Glucamine.

Methylphenobarbitone, B.P.C.

Methylprednisolone Acetate.

Metronidazole, B.P.C.

Minafen.

Mitomycin.

Myrrh Gum, Powdered, B.P.C.

Myrrh Tincture, B.P.C.

Nandrolone Decanoate.

Niclosamide.

Nicoumalone.

Nitromin.

Nux Vomica, Dry Extract, B.P.C.

Oestradiol Dipropionate, B.P.C. 1954.

Oestrone, B.P.C. 1954.

Oily Ophthalmic Vehicle, A.P.F. 1955.

Orange Peel Compound, Concentrated Infusion, B.P.C. 1954.

Orange Peel, Concentrated Infusion, B.P.C.

Orciprenaline Sulphate.

Oxymel, B.P.C.

Oxymel of Squill, B.P.C.

Oxymesterone.

Oxyphencyclimine Hydrochloride.

Oxyphenonium Bromide.

Oxytocin.

Pancreatin Enzyme, U.S.N.F. XI.

Papaveretum, B.P.C.

Para-Aminosalicylic Acid.

Paraben Ophthalmic Phosphate Buffer, A.P.F. 1955.

Paraben Ophthalmic Vehicle, A.P.F. 1955.

Paraffin Liquid Light, B.P.C.

Paramethasone Acetate.

Pectin.

d-Penicillamine Hydrochloride, B.P.C.

Penicillinase.

Penicillin, Benethamine, B.P.C.

Pentaerythritol Tetranitrate, diluted, B.P.C.

Penthienate Methobromide.

Pertussis Vaccine (Haemagglutinin Aluminium Phosphate Adsorbed).

Peru Balsam, B.P.C.

Phenazone, B.P.C.

Phenazopyridine Hydrochloride.

Phenethicillin Potassium.

Phenformin Hydrochloride.

Pheniramine Maleate.

Pheniramine Para-Aminosalicylate.

Phenol Ointment, B.P. 1948.

Phenoxymethylpenicillin, Benzathine.

Phenoxymethylpenicillin, Hydrabamine.

Phensuximide.

Phenytoin.

Phthalylsulphacetamide.

Physostigmine, B.P.C.

Pipenzolate Methobromide.

Pituitary (Posterior Lobe) Powdered, B.P.C.

Polythiazide.

Potable Water.

Potassium Chlorate, B.P.C.

Potassium, Effervescent Tablets.

Prednisolone Sodium Hemisuccinate.

Prednisolone Sodium Hemisulphate.

Prednisolone Sodium Phosphate, B.P.C.

Prednisolone Tertiary Butyl Acetate.

Protoveratrine A.

Pyrazinamide.

Pyridine Aldoxime Methiodide.

Quillaia Tincture, B.P.C.

Quinethazone.

Rauwolfia Alkaloids.

Red Back Spider Antivenene.

Rolitetracycline.

Salicylamide.

Senega, Concentrated Infusion, B.P.C.

Senna Compound Mixture, B.P.C. 1959.

Senna, Concentrated Infusion, B.P.C. 1959.

Senna Fruit Extract (Standardised).

Siberian Fir Oil, B.P.C. 1949.

Silver Picrate, B.P.C. 1949.

Silver Protein, B.P.C.

Silver Protein Mild, B.P.C.

Sobee.

Sodium Carbonate Anhydrous, B.P.C.

Sodium Edetate, B.P.C.

Sodium Folate.

Sodium Lactate.

 

Third Schedule—contined.

Sodium Nitrite, B.P.C.

Sodium Potassium Tartrate, B.P.C.

Sodium Tauroglycocholate, B.P.C. 1954.

Sorbolene, A.P.F. 1955.

Spearmint Oil, B.P.C.

Spiramycin.

Spironolactone, B.P.C.

Squill Tincture, B.P.C.

Stanolone.

Stearic Acid, B.P.C.

Strophanthus Tincture, B.P. 1948.

Strychnine, B.P.C. 1959.

Sulphacetamide, B.P.C.

Sulphadiazine Sodium, B.P.C.

Sulphadimethoxine, B.P.C.

Sulphaguanidine, B.P.C.

Sulphamerazine, B.P. 1958.

Sulphamethoxydiazine.

Sulphamethoxypyridazine N-Acetyl.

Sulphaphenazole, B.P.C.

Sulphapyridine, B.P.C. 1959.

Sulphasalazine.

Sulphathiazole, B.P.C.

Sulphinpyrazone, B.P.C.

Sulphurated Potash, B.P.C.

Sulphuric Acid, Dilute, B.P.C.

Sulphur Sublimed, B.P.C.

Sultiame.

Surgical Cement.

Sustanon.

Syrup Glucose Liquid, B.P.C.

Tacrine.

Taipan Antivenene.

Tar Ointment, B.P.C. 1939.

Tartrazine, B.P.C. 1954.

Testosterone Oenanthate.

Tetracycline.

Thenalidine.

Thenalidine Tartrate.

Theobromine, B.P.C.

Theobromine and Sodium Salicylate, B.P. 1953.

Theophylline Elixir.

Thiethylperazine.

Thioridazine.

Thiotepa.

Thyrotrophin.

Tiger Snake Antivenene.

Tolu Tincture, B.P.C. 1959.

Tragacanth (Gum Karaya).

Tretamine.

Triamcinolone, B.P.C.

Triamterene.

Triaziquone.

Tricyclamol Chloride.

Tridihexethyl Chloride.

Triethanolamine, B.P.C.

Triethanolamine Trinitrate.

Trimeprazine Tartrate, B.P.C.

Trimustine Hydrochloride.

Trinitrophenol, B.P.C. 1959.

Triprolidine Hydrochloride, B.P.C.

Vadrine.

Valerian Ammoniated Tincture, B.P.C.

Vanillin.

Vasopressin.

Vasopressin Tannate.

Velactin.

Vinblastine Sulphate.

Vincristine Sulphate.

Vinegar of Squill, B.P.C.

Viomycin Pantothenate.

Viprynium Embonate.

Vitamin A.

Vitamin D.

 

FOURTH SCHEDULE.

Regulation 12.

Additives.

Acetone, B.P.C.

Alcohol (95%), B.P.

Dilute Alcohols, B.P.

Amethocaine Hydrochloride, B.P.

Bacitracin, B.P.

Caraway Oil, B.P.C.

Carmine Solution, A.P.F.

Citronella Oil, B.P.C.

Xylene, B.P.C., 1949.

 

FIFTH SCHEDULE.

Regulation 14.

Pharmaceutical Benefits the Prescribing of Which is Subject to Conditions and Restrictions.

Pharmaceutical Benefits.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Acetylsalicylic Acid Tablets, B.P. ..
Soluble Acetylsalicylic Acid Tablets, B.P.
Compound Acetylsalicylic Acid Tablets, A.P.F.	Any disease or condition in a pensioner
Compound Acetylsalicylic Acid Tablets, B.P.C.
Soluble Compound Acetylsalicylic Acid Tablets

Fifth Schedule—continued.

Pharmaceutical Benefits.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Acrylic Resin ...............................................	Ileostomy or colostomy conditions
Alkavervir ...................................................	Hypertensive crises
Amphotericin B ............................................	Systemic fungal infection
Ampicillin Capsules .....................................	With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Ampicillin is the only appropriate antibiotic
Ampicillin Injections ....................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Aneurine Hydrochloride Tablets, B.P.	Any disease or condition in a pensioner
Ascorbic Acid Tablets, B.P. ..........................
Bemegride Injection, B.P. .............................	As an antidote to barbiturate and other hypnotic poisons
Bendrofluazide Injection ...............................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Benzol (Commercial) ...................................	Ileostomy or colostomy conditions
Betamethasone Tablets .................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Betamethasone Disodium Phosphate Injection	Intra-articular use
Bethanidine Sulphate ....................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Busulphan Tablets, B.P.	Leukaemia
Calciferol Tablets, B.P. .................................	Any disease or condition in a pensioner
With the written authority of the Director-General—
Hypoparathyroidism
Chronic hypoparathyroid tetany
Vitamin D-resistant rickets
Calciferol Solution, B.P. ...............................	Any disease or condition in a child under the age of twelve years or in a pensioner
Calcium Aminosalicylate ..............................	Tuberculosis
Calcium Gluconogalactogluconate Effervescent Tablets	Hypoparathyroidism
Caramiphen Tablets, B.P. .............................	Parkinsonism
Carbamazepine ............................................	Epilepsy
Trigeminal neuralgia
Chlorambucil Tablets, B.P. ...........................	Malignant lymphoma and related conditions
Chloramine Deodorant Tablets and Powder	Ileostomy or colostomy conditions
Chloramphenicol Capsules, B.P. ...................	Bacterial meningitis
Haemophilus influenzae infections
Rickettsial infections
Salmonella septicaemia
Typhoid and paratyphoid
Other serious infections sensitive only to Chloramphenicol
			Chloramphenicol Injections ..........................	A disease or condition specified in this column in relation to Chloramphenicol Capsules
Chloramphenicol Tablets ..............................
Chloramphenicol Oral Suspension
Chlorotrianisene Tablets ...............................	Carcinoma of the prostate
Chlorpromazine Hydrochloride .....................	Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General—
Late-stage malignancy
Radiation sickness

Fifth Schedule—continued.

Pharmaceutical Benefits.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Chlorpromazine Hydrochloride—continued	With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride or Thioridazine Hydrochloride
Chlortetracycline Capsules, B.P. ............	As an alternative to the Penicillins in a person sensitive to the Penicillins
Actinomycosis
Amoebiasis
Bacterial endocarditis (Streptococcus faecalis), acute and sub-acute
Bacillary dysentery that is resistant both to the Sulphonamides and Streptomycin Sulphate

Bronchiectasis
Brucellosis
Chancroid
Fibrocystic disease of the pancreas
Granuloma inguinale
Friedlander bacillus infections
Leptospirosis
Lymphogranuloma venereum
Muscoviscidosis
Pneumonia that is resistant both to the Penicillins and the Sulphonamides
Pre-operative prophylaxis
Primary atypical pneumonia
Psittacosis
Puerperal infections
Rat-bite fever (Spirillum minus)
Staphylococcal infections
Trachoma that is resistant to the Sulphonamides
Typhus and other rickettsial diseases
Urinary tract infections due to gram negative bacilli that are resistant to the Sulphonamides
Whooping cough (Haemophilus pertussis)
Chlortetracycline Hydrochloride Granules	A disease or condition, specified in this column in relation to Chlortetracycline Capsules
Choline Theophyllinate .........................	Any disease or condition in a patient receiving treatment in  or at an approved hospital
Cloxacillin Sodium ...............................
Compound Codeine Tablets, B.P. ...........	Any disease or condition in a pensioner
Compound Codeine Soluble Tablets, B.P.
Codeine Phosphate with Acetylsalicylic Acid Soluble Tablets
Codeine Phosphate with Acetylsalicylic Acid Tablets
Codeine Phosphate with Acetylsalicylic Acid and Phenacetin Tablets
Codeine Phosphate with Acetylsalicylic Acid, Phenacetin and Caffeine Tablets

Fifth Schedule—continued.

Pharmaceutical Benefits.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Cod Liver Oil Emulsion ..................	Any disease or condition in a child under the age of twelve years or in a pensioner
Colistin ...........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General—
Corticotrophin Injection, B.P............	A disease or condition specified in this column in relation to Cortisone Injection
Corticotrophin Gelatin Injection, B.P.
	Hypsarrhythmia
Corticotrophin Zinc Hydroxide Injection, B.P.	Salaam convulsions
	The prevention of side effects of corticosteroid J therapy
Cortisone Injection, B.P...................	With the written authority of the Director-General—
Anaemia, acquired haemolytic
Addison’s disease or other forms of adrenocortical hypoplasia
Adrenalectomy, total
Adrenogenital syndrome
Agranulocytosis
Behcet’s syndrome
Cranial arteritis
Cushing’s syndrome, including hyperadrenocorticalism
Dermatitis, acute exfoliative
Dermatomyositis
Encephalomyelitis
Encephalomyelitis, acute disseminated
Guillain-Barré syndrome
Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis
Hansen’s disease
Hepatitis, progressive or continuing, proven by biopsy or biochemistry
Hodgkin’s disease
Idiopathic hypercalcaemia
Inflammatory conditions of the uveal tract and retina
Keratoplasty
Leucine-sensitive hypoglycaemia
Leukaemia
Lymphosarcoma and follicular lymphoma
Metastatic breast cancer
Mycosis fungoides
Nephrosis or nephrotic syndrome
Neuro-myelitis optica
Optic neuritis following removal of tumor of the brain
Panhypopituitarism
Pemphigus
Periarteritis nodosa
Progressive transverse myelitis
Pseudohermaphroditism
Purpura, Henoch’s
Purpura, thrombocytopenic
Regional ileitis (Crohn’s disease)
Reticulum cell sarcoma
Rheumatic carditis, acute
Sarcoidosis
Scleroderma
Severe reactions of the skin and mucosa following X-ray therapy
Splenic neutropenia

Fifth Schedule—continued.

Pharmaceutical Benefits.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Cortisone Injection, B.P.—continued	Status asthmaticus
Steroid therapy prior to operation in patients under steroid therapy
Stevens-Johnson syndrome
Still’s disease in a child under the age of sixteen years
Sympathetic ophthalmitis
Systemic lupus erythematosus
Temporal arteritis
Tropical and non-tropical sprue and all forms of mal-absorption associated with those diseases
Type II Nephritis
Ulcerative colitis proven by sigmoidoscopy or radiological report
Cortisone Tablets, B.P. ....................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Cyanocobalamin Injection, B.P. (other than 1,000 microgramme strength)	Established megalocytic anaemia
Cyanocobalamin Injection, B.P. (1,000 microgramme strength)	Neuroblastoma
	Subacute combined degeneration of the cord
Cymogran ......................................	With the written authority of the Director-General, phenylketonuria
Cycloserine, B.P. ............................	Any disease or condition in a patient receiving treatment in or at  an approved hospital
Cycloserine Capsules, B.P. ………….
Demethylchlortetracycline Capsules, B.P.	A disease or condition specified in this column in relation to  Chlortetracycline Capsules
Demethylchlortetracycline Hydrochloride Oral Paediatric Drops and Oral Suspension
Deodorant Detergent Solution (Lissapol with Spearmint Oil and Cetrimide)	Ileostomy or colostomy conditions
Deoxycortone Aqueous Injections	Addison’s disease Adrenalectomy, total
Deoxycortone Acetate Injection, B.P.
Deoxycortone Trimethylacetate Injection, B.P.
Deoxycortone Acetate Implants, B.P.
Deoxycortone Acetate Tablets .........
Desferrioxamine .............................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Dexamethasone Tablets, B.P. ...........	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Dexamethasone Sodium Phosphate Injections	Intra-articular use
Dextran with Dextrose ....................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Dextran in Normal Saline ................
Dienoestrol Cream ..........................	Any disease or condition in a pensioner
Dienoestrol Tablets, B.P. .................	Carcinoma of the prostate
Mammary carcinoma
Any disease or condition in a pensioner
Dihydrostreptomycin Sulphate Injection	As an alternative to Streptomycin Sulphate in a person who is being treated for a disease or condition specified in this column in relation to Streptomycin Sulphate and who is allergic to Streptomycin Sulphate
Dihydrotachysterol ..........................	Parathyroid deficiency

Fifth Schedule—continued.

Pharmaceutical Benefits.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Diiodohydroxyquinoline Vaginal Tablet	Trichomonal or monilial vaginitis
Diiodohydroxyquinoline Effervescent Gynaecological Pessary
Diloxanide Furoate Tablets, B.P. ......	Amoebic dysentery
Dimethicone ...................................	Ileostomy or colostomy conditions
Disodium Stilboestrol Diphosphate	Carcinoma of the prostate
Dithiazanine iodide .........................	Infestations of Trichuris trichiura or Strongyloides stercoralis
Ditophal .........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Erythromycin ..................................	Staphylococcal septicaemia or pneumonia
Any gram-positive bacterial infections where these cannot be treated safely and effectively by sulphonamides or penicillins
Ethinyloestradiol Tablets, B.P. .........	Turner’s syndrome
Pre-menopausal castration syndrome
Any disease or condition in a pensioner
Ethionamide ...................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Ethisterone Tablets, B.P. .................	Turner’s syndrome
Ethyloestrenol .................................	Mammary carcinoma
Senile osteoporosis proven by radiological report
With the written authority of the Director-General, long-term corticosteroid therapy
Fludrocortisone Tablets, B.P. ...........	Addison’s disease
Fluoxymesterone Tablets, B.P. .........	Castration syndrome (male and female)
Mammary carcinoma
With the written authority of the Director-General, long-term corticosteroid therapy
Folic Acid Injection ........................	Macrocytic anaemia
Folic Acid Tablets, B.P. ..................	Sprue or the sprue-like syndrome
Folinic Acid ....................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Framycetin Sulphate Tablets ............
Fursemide ......................................
Fusidic Acid (Sodium Salt or Diethanolamine Salt)
Galactomin .....................................	With the written authority of the Director-General, galactosaemia
Griseofulvin Tablets, B.P. ...............	With the written authority of the Director-General, for use in severe tinea infections due to Microsporum, Trichophyton or Epidermophyton species which have been proven by laboratory examination
Halibut Liver Oil Capsules ..............	Any disease or condition in a pensioner
Haemophilus Influenza Bacterial Serum	Any disease or condition in a patient receiving treatment in or at an approved hospital
Hexachlorophane with Entsufon ......
Hexachlorophane with Lissapol .......
Hexachlorophane in Soap Solution
Hydrocortisone Injection .................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Hydrocortisone Acetate Injection, B.P.	Intra-articular use
Hydrocortisone Sodium Succinate Injection	Acute adrenal failure due to medical or surgical crises
Stevens-Johnson syndrome
Hydrocortisone Sodium Succinate Soluble Tablet	With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report
Hydroxocobalamin Injection, B.P. (100 microgramme strength)	Established megalocytic anaemia

Fifth Schedule—continued.

Pharmaceutical Benefits.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Hydroxocobalamin Injection, B.P. (1,000 microgramme strength)	Neuroblastoma
	Sub-acute combined degeneration of the cord
Hydroxyprogesterone Caproate ...	Habitual abortion
Isoniazid Tablets, B.P. ................	Hansen’s disease
Tuberculosis
Kanamycin Sulphate ...................	With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Kanamycin Sulphate is the only appropriate antibiotic
Levorphanol Tartrate ..................	Obstetrical use
Severe intractable pain
Liothyronine Tablets, B.P. ...........	Thyroid disorders
Lofenalac ...................................	With the written authority of the Director-General, phenylketonuria
Medroxyprogesterone Acetate .....	Endometrial carcinoma
Mercaptopurine Tablets, B.P. ......	Allergic angiitis
Leukaemia
Lupus erythematosus
Periarteritis
Mestanolone ...............................	Mammary carcinoma
With the written authority of the Director-General, long-term corticosteroid therapy
Methacycline ..............................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Methandienone Tablets, B.P. .......	Senile osteoporosis proven by radiological report With the written authority of the Director-General, long-term corticosteroid therapy
Methandriol ................................
Methenolone Acetate ..................
Methenolone Oenanthate .............	Any disease or condition in a patient receiving treatment in or at an approved hospital
Methicillin Sodium .....................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Methicillin Injection, B.P. ...........
Methotrexate Tablets ..................	Leukaemia and neo-plastic disease
Methotrexate Injections ...............	Any disease or condition in a patient receiving treatment in or at an approved hospital
Minafen .....................................	With the written authority of the Director-General, phenylketonuria
Mitomycin .................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Morphine with Tacrine Tablets ....	Severe intractable pain
Mustine Injection, B.P. ...............	Malignant lymphoma and related conditions
Nandrolone Phenylpropionate Injection, B.P.	Mammary carcinoma
	Senile osteoporosis proven by radiological report With the written authority of the Director-General, long-term corticosteroid therapy
Nandrolone Decanoate ................
Neomycin Sulphate Tablets .........	Any disease or condition in a patient receiving treatment in or at an approved hospital
Nicotinic Acid Tablets, B.P. ........	Any disease or condition in a pensioner
Nitrofurantoin Tablets, B.P. .........	Urinary tract infections
Nitrofurantoin Oral Suspension ...
Nitromin ....................................	Malignant lymphoma and related conditions
Norethandrolone .........................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Norethandrolone Tablets, B.P. .....
Novobiocin Calcium ...................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Novobiocin Sodium ....................
Novobiocin Tablets, B.P. ............
Nystatin .....................................	Proven monilia infections
Orciprenaline Sulphate ................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Oxymesterone ............................	Senile osteoporosis proven by radiological report
With the written authority of the Director-General, long-term corticosteroid therapy

Fifth Schedule—continued.

Pharmaceutical Benefits.		Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Oxytetracycline Hydrochloride Capsules	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Oxytetracycline Tablets, B.P. ................
Oxytetracycline Hydrochloride Injections
Calcium di-Oxytetracycline Oral Suspension
Calcium di-Oxytetracycline Paediatric Drops
Oxytocin Nasal Spray ...........................	Induction of labour
Pancreatin, B.P.....................................	Fibrocystic disease
	Pancreatico-duodenectomy
Pancreatin Enzyme U.S.N.F. XI ............	Pancreatic steatorrhoea
	Para-Aminosalicylic Acid .....................	Tuberculosis
Paramethasone Acetate .........................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Paraffin Liquid Emulsion ......................	Any disease or condition in a pensioner
Paraffin Liquid Emulsion with Phenolphthalein ...............................
Penicillamine .......................................	With the written authority of the Director-General, Wilson’s disease
Peritoneal Dialysis Solution ..................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Pethidine Hydrochloride with Levallorphan Tartrate	Obstetrical use
Benzylpenicillin with Streptomycin Sulphate	Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Benzylpenicillin with Procaine Penicillin and Streptomycin Sulphate
Phenacetin with Codeine Phosphate and Pentobarbitone Sodium	Any disease or condition in a pensioner
Phytomenadione Injection, B.P. ............	Antidote to anticoagulants
Pituitary, Posterior Lobe, Insufflation	Diabetes insipidus
Polymyxin B. Sulphate Injection ...........	Any disease or condition in a patient receiving treatment in or at an approved hospital
Prednisolone Sodium Phosphate Retention Enema	With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report
Prednisolone Tablets, B.P. ....................	With the written authority of the Director-General—
Nodular non-suppurative panniculitis (Christian-Weber disease)
A disease or condition specified in this column in relation to Cortisone Injection except Total adrenalectomy, Addison’s disease or other forms of adrenocortical hypoplasia
Prednisolone Acetate Injection ..............	Intra-articular use
Prednisolone Methyl Acetate Injections
Prednisolone Tertiary Butyl Acetate Injection
Prednisolone Trimethylacetate Injections
Methylprednisolone Tablets, B.P. ..........	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Methylprednisolone Capsules ...............
Prednisolone with Magnesium Trisilicate and Dried Aluminium Hydroxide Gel

Fifth Schedule—continued.

Pharmaceutical Benefits.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Prednisolone Sodium Hemisuccinate	With the written authority of the Director-General, medical or surgical crises
Prednisone Tablets, B.P. .......................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Prednisone with Magnesium Trisilicate and Dried Aluminium Hydroxide Gel
Progesterone ........................................	Habitual abortion
Protoveratrine A ...................................	Hypertensive crises
Pyrazinamide .......................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Pyridostigmine Injection, B.P. ...............	Myasthenia gravis
Pyridostigmine Tablets, B.P. .................
Pyridoxine Hydrochloride Tablets	Peripheral neuritis due to isoniazid therapy
Radiation sickness
Riboflavine Tablets ..............................	Any disease or condition in a pensioner
Senna Fruit Extract (Standardized)
Sobee ..................................................	With the written authority of the Director-General—
Galactosaemia
Lactose intolerance
Milk allergy
Sodium Aminosalicylate .......................	Tuberculosis
Sodium Folate ......................................	Macrocytic anaemia
Sprue or the sprue-like syndrome
Spiramycin ..........................................	A disease or condition specified in this column in relation to Erythromycin
Spironolactone .....................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Stanolone ............................................	Mammary carcinoma
With the written authority of the Director-General, long-term corticosteroid therapy

Stilboestrol Injection ............................	Carcinoma of the prostate
Stilboestrol Tablets, B.P. ......................	Mammary Carcinoma
Any disease or condition in a pensioner
Streptomycin Sulphate Injections ..........	Bacillary dysentery that is resistant to the Sulphonamides
Brucellosis
Chancroid
Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Friedlander bacillus infections
Haemophilus influenza infections
Plague
Pseudomonas pyocyanea infections
Rat-bite fever (Streptobacillus moniliformis)
Salmonella infections
Surgical conditions of the bowel (pro-operative and post-operative)
Surgical conditions of the thoracic organs
Tuberculosis
Tularaemia
Urinary tract infections that are resistant to the Sulphonamides
Sulphasalazine .....................................	Ulcerative colitis
Sultiame ..............................................	For use where other anticonvulsants have failed
Surgical Cement ...................................	Ileostomy or colostomy conditions
Sustanon ..............................................
Testosterone Implants, B.P. ..................
Testosterone Oenanthate .......................
Testosterone Propionate Injection, B.P.	Castration syndrome (male and female)
Testosterone Propionate Implants	Klinefelter Reifenstein Albright syndrome
Methyltestosterone Tablets, B.P. ...........	Mammary carcinoma
Methyltestosterone, B.P. .......................

Fifth Schedule—continued.

Pharmaceutical Benefits.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Tetracycline Capsules, B.P. ......................	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Tetracycline Tablets, B.P. .........................
Tetracycline Injections .............................
Tetracycline Hydrochloride, with a buffering agent—Capsules and Injection
Rolitetracycline ........................................
Tetracycline Granules ...............................
Tetracycline Paediatric Drops ...................
Tetracycline Oral Suspension ....................
Tetracycline with a buffering agent
—Paediatric Drops
Tetracycline with a buffering agent
—Oral Suspension
Tetracycline with a buffering agent and Amphotericin B	Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis
Tetracycline with a buffering agent and Nystatin	A second or repeated course of broad spectrum antibiotic therapy for a disease or condition specified in this column in relation to Chlortetracycline Capsules
Theophylline Elixir ..................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General—
Late-stage malignancy
Radiation sickness
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
	Thioridazine Tablets, B.P. .........................
	Thioridazine ............................................
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride or Thioridazine Hydrochloride
Thyrotrophin ............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Tragacanth (Gum Karaya) ........................	Ileostomy or colostomy conditions
Tretamine ................................................	Malignant lymphoma and related conditions
Triamcinolone ..........................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Triamterene .............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Triaziquone .............................................
Trifluoperazine Tablets, B.P. ....................	Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General—
Late-stage malignancy
Radiation sickness

Fifth Schedule—continued.

Pharmaceutical Benefits.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Trifluoperazine Tablets, B.P.—continued.	With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride or Thioridazine Hydrochloride
Trimetaphan Injection, B.P. ..................	Hypotensive for anaesthesia
Vadrine ...............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Vancomycin Hydrochloride ..................
Vasopressin Nasal Spray ......................	Diabetes insipidus
Velactin ...............................................	With the written authority of the Director-General—
Galactosaemia
Lactose intolerance
Milk allergy
Vinblastine Sulphate ............................	Hodgkin’s disease
Vincristine Sulphate .............................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Viomycin Sulphate ...............................
Viomycin Sulphate Injection, B.P.
Viomycin Sulphate with Viomycin Pantothenate Combination
Vitamin A with Ancurine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D	Any disease or condition in a pensioner
Vitamin A Tablets or Capsules ..............

By Authority: A. J. Arthur, Commonwealth Government Printer, Canberra.